Amy Ward
About Amy Ward
Amy Ward is a Drug Discovery Scientist at BenevolentAI with a background in biomedical sciences and experience in assay development and diagnostics.
Current Role at BenevolentAI
Amy Ward is currently employed as a Drug Discovery Scientist at BenevolentAI. Within this role, she contributes to the pharmaceutical industry's efforts to identify and develop new drug candidates. Her work leverages her extensive background in biomedical sciences and practical experience in assay development and in-vitro diagnostics.
Previous Experience at Omega Diagnostics Group
Prior to her position at BenevolentAI, Amy Ward worked as a Microarray Scientist at Omega Diagnostics Group from 2019 to 2021. During her time there, she gained valuable experience in the application of microarray technology in diagnostic tests. This role allowed her to deepen her expertise in the research, development, and manufacturing processes of diagnostic products.
Role at Immunodiagnostic Systems
Amy Ward served as an Assay Development Technician at Immunodiagnostic Systems (IDS) from 2017 to 2019. In this role, she was involved in the development of diagnostic assays, focusing on product development, testing, and quality control. Her work contributed to advancing IDS's capabilities in the field of immunodiagnostics.
Academic Background at Leeds Beckett University
Amy Ward attended Leeds Beckett University from 2014 to 2017, where she completed a Bachelor’s Degree in Biomedical Sciences with a focus on Molecular and Microbiology. She graduated with first-class honours, highlighting her academic dedication and proficiency in the subject. During her time at university, she also served as a Student Ambassador for 11 months in 2016 and completed an Undergraduate Research Prize project for two months, gaining early research experience.
Early Education and Qualifications
Amy Ward's foundational education includes achieving GCSEs from Hebburn Comprehensive School from 2007 to 2012 and A Levels from St Joseph's Catholic Academy from 2012 to 2014. These early academic experiences provided her with a solid basis in sciences, setting the stage for her later specialized education and career in biomedical sciences.